About
Omnia
The Omnia spirit underpins its service ethic, brings innovation to the fore, creates value for its customers and ensures integrity in all that it does.
The Omnia Group comprises a balanced and diversified range of complementary chemical services businesses with a broad geographic spread. The Group extracts operational synergies and efficiencies across its businesses. It has been in business since 1953 and is listed in the Chemicals sector of the Johannesburg Securities Exchange.
Audited results for the year ended 31 March 2022
- Revenue
increased to
R21 437m (FY2021: R16 436m) - Operating profit 1
increased to
R1 597m (FY2021: R1 138m) - Operating profit excluding Zimbabwe 1
increased to
R1 726m (FY2021: R774m) - Operating profit margin excluding Zimbabwe
increased by
8.2% (FY2021: 4.9%) - Profit after tax 1
increased to
R1 093m (FY2021: R607m) - Earnings per share 1 increased to
653 cents (FY2021: 364 cents) - Headline earnings per share 1 increased to
672 cents (FY2021: 361 cents) - EBITDA1,2 increased to
R2 352m (FY2021: R1 942m) - Cash position
increased to
R2 404m (FY2021: R1 833m) - Net working capital
increased to
R3 335m (FY2021: R2 820m) - Net asset value
increased to
R10 018m (FY2021: R9 739m) - Net cash
increased to
R719m (HY2021: R1.9bn net debt) - Ordinary dividend declared 275 cents per ordinary share (FY2021: 200 cents per ordinary share)
- Special dividend declared 525 cents per ordinary share (FY2021: 400 cents per ordinary share)
FOOTPRINT
![Omnia operations Footprint map [map]](/images/omnia/hm-geoscope-map-thumb-july2021.png)
Global credit rating
- Long term A with a stable outlook (FY2021: BBB+)
- Short term A1 with a stable outlook (FY2021: A2)
Disciplined strategy execution enhanced operating performance
Optimised supply chain and integrated manufacturing facilities improved reliability and throughput
Disciplined cash management in a rising commodity price cycle underpinned strong financial position
Prudent capital management resulted in value creation for stakeholders
2 Excludes impairments of R29 million.